Latest news

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised COVID-19 injection from Pfizer Inc...

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Roche’s Xofluza approved by European Commission for children’s influenza treatment

The EC (European Commission) has approved Roche’s influenza treatment called Xofluxa, targeted toward children aged over a...

Delivering mRNA Into Extracellular Vesicles Decreases Wrinkles in Mice, Study Finds

Extracellular vesicles (EVs) have been found to be a viable alternative to lipid nanoparticles for the delivery...

Alphabet’s health subsidiary Verily cuts staff by 15% in a bid to strategize and reorganize

In an email shared with Verily employees recently, the company CEO Stephen Gillett announced that they will...

AstraZeneca receives FDA approval for its Asthma drug AirSupra

AstraZeneca has successfully received approval for its Asthma therapy- AirSupra. AstraZeneca (AZ) representative stated...

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

Fate, Century, and TCR2 Therapeutics have planned to reorganize in the new year signaling longer plans for...

Spectrum Labs Recalls Three Batches of Epinephrine Following Discoloration Complains

Spectrum Laboratory Products has voluntarily recalled all...

Pfizer Steps Back From Early-Stage Rare Disease R&D

Pfizer is withdrawing from research and development...

CDC reports a new strain of omicron taking over the U.S.

CDC has warned of a new variant of omicron that has spread across the U.S. Concerns have...

Amazon Inches Closer to Acquiring One Medical

Amazon has moved closer to finalizing its $3.9 billion acquisition of One Medical after receiving approval from...

Novartis pays $245 million to close Exforge lawsuit

Novartis has made the decision to resolve all legal pay-for-delay disputes by making final settlements. Novartis will...

Patient Engagement – What History Teaches Us About Pharma’s Future Evolution

The pharmaceutical industry continues to grow by...

Study shows Apple AirPods can disrupt the market of OTC hearing aids

This year the FDA allowed the over-the-counter...

In latest developments, HistoSonics sees greater funding and board addition

HistoSonics, a private medical device company, is...

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

Trikafta was approved by FDA for the treatment of Cystic Fibrosis in patients aged 6 to 11 years, after receiving approval to be used in patients of ages 12 and up

Eton Pharma gets FDA nod on Rezipres® for treatment of hypotension in anesthesia settings

Rezipres, an ephedrine HCL (hydrochloride) injectable manufactured by Eton Pharmaceuticals, has been approved by FDA to treat

Commercial

Disappointing sales prompt AstraZeneca to pull out leukemia drug Lumoxiti from U.S. market

In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia...

Sanofi’s Venture Capital units to receive over $750 million in investment to boost firm’s investment capabilities 

After a successful last year in which Sanofi Ventures made its second-highest number of deals, 10 rounds...

Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication

Spiral Therapeutics has recently closed an $8.25 million financing round for the phase 2 research and development...

Alphabet’s health subsidiary Verily cuts staff by 15% in a bid to strategize and reorganize

In an email shared with Verily employees recently, the company CEO Stephen Gillett announced that they will...

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

Fate, Century, and TCR2 Therapeutics have planned to reorganize in the new year signaling longer plans for...

Amazon Inches Closer to Acquiring One Medical

Amazon has moved closer to finalizing its $3.9 billion acquisition of One Medical after receiving approval from...

Information Technology

Canon Healthcare announces new subsidiary in a bid to expand presence in the U.S.

Japanese tech giant Canon has announced the opening of its second med...

Agreement for the commercialization of mammography AI reached between iCAD and Google Health

A deal was penned between medical tech company iCAD and Google Health...

Ionis And Metagenomi Team Up For Ambitious Genetic Targeting Pact

Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a...

BioMed X and Sanofi join hands to use AI for drug development

The failure of new drug therapy candidates in the clinical development process...

Regulatory

Roche’s Xofluza approved by European Commission for children’s influenza treatment

The EC (European Commission) has approved Roche’s...

Research & Development

FDA and CDC exploring unlikely relation between COVID-19 vaccine and stroke

The FDA and CDC have brought out new revelations that the revised...

Delivering mRNA Into Extracellular Vesicles Decreases Wrinkles in Mice, Study Finds

Extracellular vesicles (EVs) have been found to be a viable alternative to...

Spiral Therapeutics completes $8.25M financing for phase 2 trial of hearing medication

Spiral Therapeutics has recently closed an $8.25 million financing round for the...

Pfizer Steps Back From Early-Stage Rare Disease R&D

Pfizer is withdrawing from research and development for rare diseases in their...

Market Access

AstraZeneca teams up with G42 Healthcare to increase drug production in Abu Dhabi

AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture...

Breyanzi’s case strengthened by Bristol Myers amidst the confrontation with Gilead

A year ago when Breyanzi’s second-line LBCL (large B-cell lymphoma) key data...

Biopharma newcomer Resilience buys AstraZeneca’s Ohio facility

AstraZeneca’s Ohio facility, which was part of the United States covid vaccine...

Novo Nordisk expands facility to increase production

Novo Nordisk will invest $744 million to expand its clinical production facilities...

Merck making their move toward expansion in France

Merck, a leading German science and technology...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival